Back
Grand Canyon Education, Inc. Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Sell
41
LOPE
Grand Canyon Education, Inc.
Last Price:
$168.55
Seasonality Move:
5.96%
Buy
60
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$781.97
Seasonality Move:
12.13%
Sell
41
Grand Canyon Education, Inc. (LOPE)
is a Sell
Is Grand Canyon Education, Inc. a Buy, Sell or Hold?
-
The current Grand Canyon Education, Inc. [LOPE] share price is $168.21. The Score for LOPE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
LOPE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $783.71. The Score for REGN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LOPE Stock Price Chart
What is Grand Canyon Education, Inc.'s stock price today?
-
The Grand Canyon Education, Inc. share price today is $168.21The current trend is relatively stagnant and LOPE is experiencing slight selling pressure.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $783.71Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
LOPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.96 | Sell |
| Relative Strength Index (14 RSI): | 55.51 | Buy |
| Chaikin Money Flow: | -41112 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (154.39 - 164.51) | Buy |
| Bollinger Bands (100): | (167.57 - 213.35) | Sell |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 204.17 | Buy |
| Relative Strength Index (14 RSI): | 67.2 | Buy |
| Chaikin Money Flow: | -261329 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (720.67 - 774.53) | Buy |
| Bollinger Bands (100): | (555.56 - 709.04) | Buy |
LOPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 165.95 | Buy |
| 20-day SMA: | 159.8 | Buy |
| 50-day SMA: | 175.6 | Sell |
| 200-day SMA: | 185.42 | Sell |
| 8-day EMA: | 165.48 | Buy |
| 20-day EMA: | 163.77 | Buy |
| 50-day EMA: | 172.42 | Sell |
| 200-day EMA: | 180.51 | Sell |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 764.21 | Buy |
| 20-day SMA: | 747.28 | Buy |
| 50-day SMA: | 691.09 | Buy |
| 200-day SMA: | 601.8 | Buy |
| 8-day EMA: | 603.24 | Buy |
| 20-day EMA: | 348.3 | Buy |
| 50-day EMA: | 164.33 | Buy |
| 200-day EMA: | 44.8 | Buy |
Grand Canyon Education, Inc. Earnings Growth & LOPE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $0.85 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.
Grand Canyon Education, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||